retatrutide clinical trial phase retatrutide 3: TRIUMPH Program Results 2026 Eli Lilly infiltrates anti-obesity market

This is important practical knowledge

Semaglutide (Ozempic, Wegovy) is a GLP-1 mono agonist

dipeptidyl peptidase-4, an enzyme expressed on the surface of cells, terminates the blood glucose lowering action of GLP-1

FDA Fast Track designation for tirzepatide for the treatment of adults with obesity, or overweight with weight-related comorbidities

Both peptides are currently FDA-approved and available as effective weight loss treatments.

Is GLP-1 the Same as Ozempic for Medical Weight Loss GLP-1 medications are a class of drugs designed to aid weight loss by regulating appetite and blood sugar, and Ozempic is one of the leading brands within this group